Diagnosis and Management of Crohn Disease
This JAMA Clinical Guidelines Synopsis summarizes the 2018 American College of Gastroenterology ACG guideline on management of Crohn disease in adults.
View Article'Gutonachip' research aims to find personalized treatment for Crohn's disease
University of Texas at Austin Thanks to a new $1.8 million grant from The Helmsley Charitable Trust UT Austin Engineer Hyun Jung Kim will apply his 'GutOnAChip' technology to better understand Crohn's...
View ArticleInnovative 'gutonachip' technology will help better understand Crohn's disease
To model human health and disease organonachip technology mimics the human body's organ structure functionality and physiology in a controlled environment.
View ArticleMKSAP 28yearold woman with decreased exercise tolerance and ice cravings
Test your medicine knowledge with theÂMKSAP challenge in partnership with theÂAmerican College of Physicians. A 28yearold woman is evaluated for decreased exercise tolerance and ice cravings for the...
View ArticleVitro Biopharma Receives ISO 13485 Certification Supporting its Stem Cell...
GOLDEN CO ACCESSWIRE April 30 2019 Vitro Diagnostics Inc. OTC PINK VODG dba Vitro Biopharma one of the world's emerging biotechnology companies focused on allogeneic Mesenchymal Stem Cell "MSC"...
View ArticleRedHill Biopharma Reports First Quarter 2019 Financial Results and...
Key Highlights and Upcoming Milestones NDA submitted to the FDA for Talicia for H. pylori infection with potential U.S. commercial launch in Q42019 assuming FDA approvalFDA meeting planned for H22019...
View ArticleAnalysis Showed Oral Ozanimod Reduced Brain Volume Loss Across All Age...
Patients across all age subgroups treated with ozanimod lost less cortical grey matter volume than did those treated with interferon beta1a over 24 months Data from new analysis of pivotal ozanimod...
View ArticleIn Men Low BMI Tied to Later Inflammatory Bowel Disease
TUESDAY May 7 2019 Low body mass index BMI among men entering adult life is associated with an increased incidence of Crohn disease CD and ulcerative colitis UC up to 40 years later according to a...
View ArticleReport Card Finds Top Health Insurers and PBMs Impose Significant...
New National Initiative Established to Advocate for DoctorPatient Led Decisions vs. Harmful Step Therapy Interventions Most of the nations top health insurers and PBMs receive a failing grade in...
View ArticleStudy reveals increased risk of cancer early death in young patients with...
A new study revealed an increased risk of cancer and early death in individuals who developed inflammatory bowel diseaseincluding ulcerative colitis UC and Crohn's disease CDduring childhood.
View ArticleU.S. Food & Drug Administration Accepts Takedas Biologics License Application...
An additional treatment modality would provide more flexibility in how patients receive vedolizumab a biologic with a gutselective mode of action Vedolizumab set to be the only maintenance therapy to...
View ArticleOfflabel Prescriptions for Crohn's Disease or UC
This study assessed the prevalence and characteristics of offlabel prescribing for IBD. Which drugs are the most commonly prescribed offlabel Alimentary Pharmacology & Therapeutics
View ArticleBreath Analysis Shows Promise in Distinguishing IBD Types
A breath analyzer can identify inflammatory bowel disease IBD in affected individuals and distinguish ulcerative colitis UC from Crohn's disease CD a pilot study reveals. Reuters Health Information
View ArticleInflammatory disease linked to depression and anxiety
Higher levels of depression and anxiety are experienced by people with inflammatory disease particularly those who are younger says research in the Annals of the Rheumatic Disease. Scientists looked at...
View ArticlePostop Complications With Preop AntiTNF Agents for CD
Does preoperative exposure to antiTNF agents increase the risk for postoperative infectious complications in patients with Crohn's disease Alimentary Pharmacology & Therapeutics
View ArticleTakeda Reports FY2018 Full Year Results and Issues FY2019 Guidance
Excellent FY2018 results driven by key growth products and strict Opex discipline with Legacy Takeda1 greatly exceeding original guidance and absorbing Shire acquisitionrelated costs In FY2019 contin...
View ArticleLandos Biopharma Announces Publication of Results from FirstinHuman Phase 1...
Landos Biopharma Inc. a clinicalstage biopharmaceutical company focused on the discovery and development of firstinclass oral therapeutics for patients with autoimmune diseases announced the...
View ArticleNeuClone to Initiate Phase I Clinical Trial of Stelara Ustekinumab Biosimilar...
SYDNEY May 15 2019 PRNewswire NeuClone Pharmaceuticals Ltd. NeuClone a clinicalstage biopharmaceutical company exclusively focused on developing highquality biosimilar products today announced it will...
View ArticleAdultonset inflammatory bowel disease tied to higher mortality
While the onset of inflammatory bowel disease ulcerative colitis or Crohn's disease in adulthood is tied to a higher mortality the actual number of deaths has been falling a Swedish study from...
View Article